Clinicopathological and mutational differences between tumors with multiple metastases and single lung metastasis in colorectal cancer

Yanai,Yuka; Hayashi,Takuo; Akazawa,Yoichi; Yatagai,Noboru; Tsuyama,Sho; Yao,Takashi; Saito,Tsuyoshi

doi:10.3892/ol.2020.11627

Clinicopathological and mutational differences between tumors with multiple metastases and single lung metastasis in colorectal cancer

Authors:
- Yuka Yanai
- Takuo Hayashi
- Yoichi Akazawa
- Noboru Yatagai
- Sho Tsuyama
- Takashi Yao
- Tsuyoshi Saito
View Affiliations

Affiliations: Department of Human Pathology, Juntendo University, Graduate School of Medicine, Tokyo 113‑8421, Japan, Department of Gastroenterology, Juntendo University, Graduate School of Medicine, Tokyo 113‑8421, Japan
Published online on: May 14, 2020 https://doi.org/10.3892/ol.2020.11627
Pages: 541-550
Copyright: © Yanai et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cancer metastasis, particularly multiple metastatic cancer, is a significant event that affects patient prognosis. However, single metastasis can be treated by partial resection, although the clinicopathological and molecular profile of single lung metastasis has not been thoroughly elucidated. The present study examined tumor heterogeneity by comparing the mutation status between primary colorectal cancer (CRC) and corresponding metastatic lesions to identify prognostic factors associated with single lung metastasis and multiple metastases. The present study enrolled 31 cases of CRC; 20 cases with multiple metastases and 11 cases with single lung metastasis. Clinicopathologically, all cases with multiple metastases were tubular adenocarcinoma, and 3/11 cases with single metastasis were mucinous adenocarcinoma originating from the left side, the remaining 8 cases were tubular adenocarcinoma from the left side. CRC cases with multiple metastases exhibited more frequent vascular invasion, but not lymphatic invasion, than those with single lung metastasis. Furthermore, CRC with multiple metastases was associated with strong tumor budding (P=0.04). Patients with CRC with multiple metastases had lower recurrence‑free survival rates compared with those with single lung metastasis (P=0.02). However, there was no significant difference between these two groups in terms of overall survival rates. A next‑generation sequencing cancer hotspot panel was used to analyze a heterochronous multiple metastases case, including brain metastasis. Sanger sequencing, immunohistochemistry and microsatellite instability were examined for all 31 cases to reveal the molecular features. KRAS and TP53 mutation signatures were largely preserved throughout the metastatic events. TP53/APC mutations and overexpression of p53 appeared to be associated with the presence of lymphovascular invasion and strong tumor budding, respectively, although these differences were not statistically significant. Early relapses in patients with CRC could be a sign for eventual multiple metastases, although these may not affect the overall survival of patients with CRC. Considerable mutational changes were seemingly rare during metastatic events in patients with CRC.

View Figures

View References

1	Taki K, Ohmuraya M, Tanji E, Komatsu H, Hashimoto D, Semba K, Araki K, Kawaguchi Y, Baba H and Furukawa T: GNAS(R201H) and Kras(G12D) cooperate to promote murine pancreatic tumorigenesis recapitulating human intraductal papillary mucinous neoplasm. Oncogene. 35:2407–2412. 2016. View Article : Google Scholar : PubMed/NCBI
2	Brierley JD, Gospodarowicz MK and Wittekind C: TNM classification of malignant tumors, 8^th edition. Wiley-Blackwell. 2017.
3	Lee VWK and Chan KF: Tumor budding and poorly-differentiated cluster in prognostication in stage II colon cancer. Pathol Res Pract. 214:402–407. 2018. View Article : Google Scholar : PubMed/NCBI
4	Akazawa Y, Saito T, Hayashi T, Yanai Y, Tsuyama S, Akaike K, Suehara Y, Takahashi F, Takamochi K, Ueyama H, et al: Next-generation sequencing analysis for gastric adenocarcinoma with enteroblastic differentiation: Emphasis on the relationship with hepatoid adenocarcinoma. Hum Pathol. 78:79–88. 2018. View Article : Google Scholar : PubMed/NCBI
5	Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN and Srivastava S: A national cancer institute workshop on microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 58:5248–5257. 1998.PubMed/NCBI
6	Umetani N, Sasaki S, Watanabe T, Ishigami H, Ueda E and Nagawa H: Diagnostic primer sets for microsatellite instability optimized for a minimal amount of damaged DNA from colorectal tissue samples. Ann Surg Oncol. 7:276–280. 2000. View Article : Google Scholar : PubMed/NCBI
7	Cancer Genome Atlas Network, . Comprehensive molecular characterization of human colon and rectal cancer. Nature. 487:330–337. 2012. View Article : Google Scholar : PubMed/NCBI
8	Jass JR, Young J and Leggett BA: Evolution of colorectal cancer: Change of pace and change of direction. J Gastroenterol Hepatol. 17:17–26. 2002. View Article : Google Scholar : PubMed/NCBI
9	Miyaki M, Iijima T, Kimura J, Yasuno M, Mori T, Hayashi Y, Koike M, Shitara N, Iwama T and Kuroki T: Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer. Cancer Res. 59:4506–4509. 1999.PubMed/NCBI
10	Parnaby CN, Bailey W, Balasingam A, Beckert L, Eglinton T, Fife J, Frizelle FA, Jeffery M and Watson AJ: Pulmonary staging in colorectal cancer: A review. Colorectal Dis. 14:660–670. 2012. View Article : Google Scholar : PubMed/NCBI
11	Mitry E, Guiu B, Cosconea S, Jooste V, Faivre J and Bouvier AM: Epidemiology, management and prognosis of colorectal cancer with lung metastases: A 30-year population-based study. Gut. 59:1383–1388. 2010. View Article : Google Scholar : PubMed/NCBI
12	Boeckx N, Koukakis R, Op de Beeck K, Rolfo C, Van Camp G, Siena S, Tabernero J, Douillard JY, André T and Peeters M: Primary tumor sidedness has an impact on prognosis and treatment outcome in metastatic colorectal cancer: Results from two randomized first-line panitumumab studies. Ann Oncol. 28:1862–1868. 2017. View Article : Google Scholar : PubMed/NCBI
13	Kanemitsu Y, Kato T, Hirai T, Yasui K, Morimoto T, Shimizu Y, Kodera Y and Yamamura Y: Survival after curative resection for mucinous adenocarcinoma of the colorectum. Dis Colon Rectum. 46:160–167. 2003. View Article : Google Scholar : PubMed/NCBI
14	Jimi S, Hotokezaka M, Ikeda T, Uchiyama S, Hidaka H, Maehara N, Ishizaki H and Chijiiwa K: Clinicopathological features, postoperative survival and prognostic variables for cancer-related survival in patients with mucinous colorectal carcinoma. Surg Today. 45:329–334. 2015. View Article : Google Scholar : PubMed/NCBI
15	Yamaguchi T, Taniguchi H, Fujita S, Sekine S, Yamamoto S, Akasu T, Kushima R, Tani T, Moriya Y and Shimoda T: Clinicopathological characteristics and prognostic factors of advanced colorectal mucinous adenocarcinoma. Histopathology. 61:162–169. 2012. View Article : Google Scholar : PubMed/NCBI
16	Ott C, Gerken M, Hirsch D, Fest P, Fichtner-Feigl S, Munker S, Schnoy E, Stroszczynski C, Vogelhuber M, Herr W, et al: Advanced mucinous colorectal cancer: Epidemiology, prognosis and efficacy of chemotherapeutic treatment. Digestion. 98:143–152. 2018. View Article : Google Scholar : PubMed/NCBI
17	Reggiani Bonetti L, Barresi V, Bettelli S, Caprera C, Manfredini S and Maiorana A: Analysis of KRAS, NRAS, PIK3CA, and BRAF mutational profile in poorly differentiated clusters of KRAS-mutated colon cancer. Human Pathol. 62:91–98. 2017. View Article : Google Scholar
18	Yaeger R, Chatila WK, Lipsyc MD, Hechtman JF, Cercek A, Sanchez-Vega F, Jayakumaran G, Middha S, Zehir A, Donoghue MTA, et al: Clinical sequencing defines the genomic landscape of metastatic colorectal cancer. Cancer Cell. 33:125–136.e123. 2018. View Article : Google Scholar : PubMed/NCBI
19	Greaves M and Maley CC: Clonal evolution in cancer. Nature. 481:306–313. 2012. View Article : Google Scholar : PubMed/NCBI
20	Maley CC, Aktipis A, Graham TA, Sottoriva A, Boddy AM, Janiszewska M, Silva AS, Gerlinger M, Yuan Y, Pienta KJ, et al: Classifying the evolutionary and ecological features of neoplasms. Nat Rev Cancer. 17:605–619. 2017. View Article : Google Scholar : PubMed/NCBI
21	Siegmund KD, Marjoram P, Woo YJ, Tavaré S and Shibata D: Inferring clonal expansion and cancer stem cell dynamics from DNA methylation patterns in colorectal cancers. Proc Natl Acad Sci USA. 106:4828–4833. 2009. View Article : Google Scholar : PubMed/NCBI
22	Giannakis M, Mu XJ, Shukla SA, Qian ZR, Cohen O, Nishihara R, Bahl S, Cao Y, Amin-Mansour A, Yamauchi M, et al: Genomic correlates of immune-cell infiltrates in colorectal carcinoma. Cell Rep. 17:12062016. View Article : Google Scholar : PubMed/NCBI
23	Schell MJ, Yang M, Teer JK, Lo FY, Madan A, Coppola D, Monteiro AN, Nebozhyn MV, Yue B, Loboda A, et al: A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC. Nat Comm. 7:117432016. View Article : Google Scholar
24	El-Deiry WS, Vijayvergia N, Xiu J, Scicchitano A, Lim B, Yee NS, Harvey HA, Gatalica Z and Reddy S: Molecular profiling of 6,892 colorectal cancer samples suggests different possible treatment options specific to metastatic sites. Cancer Biol Ther. 16:1726–1737. 2015. View Article : Google Scholar : PubMed/NCBI
25	Pereira AA, Rego JF, Morris V, Overman MJ, Eng C, Garrett CR, Boutin AT, Ferrarotto R, Lee M, Jiang ZQ, et al: Association between KRAS mutation and lung metastasis in advanced colorectal cancer. Br J Cancer. 112:424–428. 2015. View Article : Google Scholar : PubMed/NCBI
26	Rajakannu M, Magdeleinat P, Vibert E, Ciacio O, Pittau G, Innominato P, SaCunha A, Cherqui D, Morère JF, Castaing D and Adam R: Is cure possible after sequential resection of hepatic and pulmonary metastases from colorectal cancer? Clin Colorectal Cancer. 17:41–49. 2018. View Article : Google Scholar : PubMed/NCBI
27	Wiegering A, Riegel J, Wagner J, Kunzmann V, Baur J, Walles T, Dietz U, Loeb S, Germer CT, Steger U and Klein I: The impact of pulmonary metastasectomy in patients with previously resected colorectal cancer liver metastases. PLoS One. 12:e01739332017. View Article : Google Scholar : PubMed/NCBI
28	Mackinnon AC Jr, Luevano A, de Araujo LC, Rao N, Le M and Suster S: Cribriform adenocarcinoma of the lung: Clinicopathologic, immunohistochemical, and molecular analysis of 15 cases of a distinctive morphologic subtype of lung adenocarcinoma. Mod Pathol. 27:1063–1072. 2014. View Article : Google Scholar : PubMed/NCBI
29	Matsushima J, Yazawa T, Suzuki M, Takahashi Y, Ota S, Nakajima T, Yoshino I, Yokose T, Inoue T, Kawahara K and Nakatani Y: Clinicopathological, immunohistochemical, and mutational analyses of pulmonary enteric adenocarcinoma: Usefulness of SATB2 and β-catenin immunostaining for differentiation from metastatic colorectal carcinoma. Hum Pathol. 64:179–185. 2017. View Article : Google Scholar : PubMed/NCBI